Skip to main content

WPI 2196 Pill - orange & white capsule/oblong

Pill with imprint WPI 2196 is Orange & White, Capsule/Oblong and has been identified as Phentermine Hydrochloride and Topiramate Extended-Release 3.75 mg / 23 mg. It is supplied by Teva Pharmaceuticals USA, Inc.

Phentermine/topiramate is used in the treatment of Weight Loss (Obesity/Overweight) and belongs to the drug class anorexiants. Not for use in pregnancy. Phentermine/topiramate 3.75 mg / 23 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).

Images for WPI 2196

Phentermine hydrochloride and topiramate extended-release 3.75 mg / 23 mg WPI 2196

Phentermine Hydrochloride and Topiramate Extended-Release

Imprint
WPI 2196
Strength
3.75 mg / 23 mg
Color
Orange & White (white opaque cap and orange opaque body)
Shape
Capsule/Oblong (capsule)
Availability
Prescription only
Drug Class
Anorexiants
Pregnancy Category
X - Not for use in pregnancy
CSA Schedule
4 - Some potential for abuse
Labeler / Supplier
Teva Pharmaceuticals USA, Inc.
National Drug Code (NDC)
00480-3297

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.